Omitting the 5-fluorouracil bolus in metastatic colorectal cancer: impact on survival and toxicity in a retrospective multicentre cohort.

Sohaib A, Hebesh EH, Elabd NS, Korani O, Amin MT, Abd-Elhafiz HI, Badawy AM, Hosny S

Open source

DOI
10.5114/wo.2026.162227
Published
2026
Container
Contemporary oncology (Poznan, Poland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5114/wo.2026.162227,
  title = {Omitting the 5-fluorouracil bolus in metastatic colorectal cancer: impact on survival and toxicity in a retrospective multicentre cohort.},
  author = {Sohaib A and Hebesh EH and Elabd NS and Korani O and Amin MT and Abd-Elhafiz HI and Badawy AM and Hosny S},
  year = {2026},
  journal = {Contemporary oncology (Poznan, Poland)},
  doi = {10.5114/wo.2026.162227},
  url = {https://doi.org/10.5114/wo.2026.162227}
}

RIS

TY  - JOUR
TI  - Omitting the 5-fluorouracil bolus in metastatic colorectal cancer: impact on survival and toxicity in a retrospective multicentre cohort.
AU  - Sohaib A
AU  - Hebesh EH
AU  - Elabd NS
AU  - Korani O
AU  - Amin MT
AU  - Abd-Elhafiz HI
AU  - Badawy AM
AU  - Hosny S
PY  - 2026
JO  - Contemporary oncology (Poznan, Poland)
DO  - 10.5114/wo.2026.162227
UR  - https://doi.org/10.5114/wo.2026.162227
ER  - 

APA

A, S., EH, H., NS, E., O, K., MT, A., HI, A., AM, B., & S, H. (2026). Omitting the 5-fluorouracil bolus in metastatic colorectal cancer: impact on survival and toxicity in a retrospective multicentre cohort.. Contemporary oncology (Poznan, Poland). https://doi.org/10.5114/wo.2026.162227

Source records